Antibody response to four doses of SARS-CoV-2 vaccine in rare autoimmune rheumatic diseases: an observational study.
Leher GumberHannah JacksonNancy GomezGeorgina HopkinsDavis TucisMithun ChakravortyPatrick TigheMatthew J GraingeMegan RutterAlastair FerraroSheila PowerMarie-Josèphe PradèrePeter C LanyonFiona A PearceLucy FaircloughPublished in: Rheumatology advances in practice (2023)
Although the booster dose increased anti-spike IgG and seropositivity rates, some people with RAIRD, particularly those on rituximab, had insufficient antibody levels despite three or four doses.